Omalizumab Before Onset of Exacerbations

Clinical trial NCT05332067 · RECRUITING

Trial details

NCT number: NCT05332067
Sponsor: Children's National Research Institute
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Asthma in Children Atopy Viral Upper Respiratory Infection

Start date: 2022-05-01
Primary completion: 2028-01-01
Enrollment: 300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.